A Faster Solution with Increased Resolution for Determining Chromatographic Identity and Absence of OSCS in Heparin Sodium

Importance of the Topic

Heparin is a widely used anticoagulant, and ensuring its identity and purity is vital to patient safety. The 2008 contamination crisis involving oversulfated chondroitin sulfate (OSCS) highlighted the need for fast, reliable analytical methods to detect trace impurities in heparin products.

Objectives and Study Overview

The primary goal was to develop a chromatographic method that offers higher resolution, faster analysis, and avoids toxic perchlorate eluents. The study focused on separating and detecting dermatan sulfate (DS) and OSCS in heparin sodium, improving on the current USP monograph method.

Instrumentation

This method employed a high-capacity strong anion-exchange column (IonPac AS11-HC, 2 × 250 mm) connected to an ion chromatography system with UV detection at 215 nm. A microbore flow cell and micro-volume injection minimized eluent use and enhanced sensitivity.

Methodology

Separation was achieved using a binary gradient of deionized water (A) and 2.5 M NaCl in 20 mM Tris buffer at pH 3.0 (B). The gradient shifted from 5 % B to 95 % B over 26 min at 40 °C and 0.20 mL/min. Standards of heparin, DS, and OSCS were used for system suitability. Baseline subtraction was applied via chromatography software to improve integration accuracy.

Results and Discussion

The method delivered baseline resolution between DS and heparin (Rs ≈ 2.04) and between heparin and OSCS (Rs ≈ 1.93), exceeding USP requirements. Total run time was reduced to 40 min. Precision over 82 injections across three days showed retention time RSD < 0.5 % and peak area RSD < 6.0 %. The high-capacity column prevented overload and maintained stable performance.

Benefits and Practical Applications

• Eliminates perchlorate in the mobile phase, reducing environmental and health risks.
• Halves analysis time compared to the current USP method, improving laboratory throughput.
• Enhances detection accuracy for critical heparin impurities.
• Demonstrates robustness suitable for routine quality control in pharmaceutical manufacturing.

Future Trends and Potential Applications

Future developments may include coupling with mass spectrometry for structural confirmation and lower detection limits. Automation of sample handling and data analysis could further boost throughput and compliance with evolving regulatory expectations. Expanding the method to detect additional glycosaminoglycan impurities can broaden its utility.

Conclusion

The presented anion‐exchange chromatography method offers a fast, high‐resolution, and safer alternative for monitoring DS and OSCS in heparin sodium. Its robustness, precision, and reduced run time make it an excellent choice for routine QC environments, ultimately safeguarding patient health.

References

1. Guerrini M. et al. Orthogonal Analytical Approaches to Detect Potential Contaminants in Heparin. PNAS. 2009.
2. United States Pharmacopeia. Heparin Sodium Monograph. USP 34–NF 29. 2011.
3. Trehy M.L. et al. Analysis of Heparin Sodium by SAX/HPLC for Contaminants and Impurities. J Pharm Biomed Anal. 2009.